SECTION 1. Relative to controlled release Hydromorphone.
Chapter 94C of the General Laws, as appearing in the 2004 Official Edition, is hereby amended by inserting after section 3 the following section:-
Section 3A. Notwithstanding sections 2 and 3, any preparation which contains hydromorphone, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers, if manufactured so as to delay absorption into the blood system, unless the preparation contains one or more active non-narcotic ingredients in recognized therapeutic amounts, shall be in schedule I.
SECTION 2. Section 31 of said chapter 94C of the General Laws, as so appearing, is hereby amended by inserting after line 85, the following paragraph:-
Any preparation, which contains hydromorphone, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers, if manufactured so as to delay absorption into the blood system, unless the preparation contains one or more active non-narcotic ingredients in recognized therapeutic amounts.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.